NCT02634697View on ClinicalTrials.gov

Impact of the Relaxation Response Resiliency Program on Patients With Atrial Fibrillation

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

January 9, 2017

Study Completion Date

January 9, 2017

Conditions
Atrial FibrillationStressQuality of LifeAnxietyDepressionHostility
Interventions
BEHAVIORAL

Relaxation Response Resiliency Program

8-week group intervention teaching relaxation and psychological resiliency enhancing skills. Topics include the relaxation response, meditation, and yoga

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Benson-Henry Institute for Mind Body Medicine

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02634697 - Impact of the Relaxation Response Resiliency Program on Patients With Atrial Fibrillation | Biotech Hunter | Biotech Hunter